Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: KDM5-C70
  • Price: $700.0/100mg $1300.0/250mg $2600.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1596348-32-1

1596348-32-1 structure
1596348-32-1 structure
  • Name: KDM5-C70
  • Chemical Name: 4288BE400F
  • CAS Number: 1596348-32-1
  • Molecular Formula: C17H28N4O3
  • Molecular Weight: 336.429
  • Catalog: Signaling Pathways Epigenetics Histone Demethylase
  • Create Date: 2018-06-21 17:53:30
  • Modify Date: 2024-01-10 16:40:42
  • KDM5-C70 is an ethyl ester derivative of KDM5-C49 and a potent, cell-permeable and pan-KDM5 histone demethylase inhibitor. KDM5-C70 has an antiproliferative effect in myeloma cells, leading to genome-wide elevation of H3K4me3 levels[1][2].

Name 4288BE400F
Synonyms 4288BE400F
4-Pyridinecarboxylic acid, 2-[[[2-[[2-(dimethylamino)ethyl]ethylamino]-2-oxoethyl]amino]methyl]-, ethyl ester
Ethyl 2-{[(2-{[2-(dimethylamino)ethyl](ethyl)amino}-2-oxoethyl)amino]methyl}isonicotinate
Description KDM5-C70 is an ethyl ester derivative of KDM5-C49 and a potent, cell-permeable and pan-KDM5 histone demethylase inhibitor. KDM5-C70 has an antiproliferative effect in myeloma cells, leading to genome-wide elevation of H3K4me3 levels[1][2].
Related Catalog
Target

KDM5 histone demethylase[1][2]

In Vitro KDM5-C70 (10-9-10-5 M; 7 days; MM.1S myeloma cells) treatment shows antiproliferative effects after 7 days of treatment at elevated concentrations (estimated 50% reduction of viability/proliferation for KDM5-C70 at ~20 μM)[1]. KDM5-C70 (50 μM; 7 days; MM.1S myeloma cells) treatment decreases the level of phosphorylation of retinoblastoma protein (Rb), while leaving the total level of phosphorylated Rb (pRb) unchanged, indicating impairment of cell cycle progression[1]. Chromatin immunoprecipitation followed by next-generation sequencing shows an increase in H3K4me3 levels around transcription start sites with KDM5-C70 but little change with GSK467A at 50 μM inhibitor concentrations[1]. Cell Viability Assay[1] Cell Line: MM.1S myeloma cells Concentration: 10-9-10-5 M Incubation Time: 7 days Result: Showed antiproliferative effects after 7 days of treatment at elevated concentrations. Western Blot Analysis[1] Cell Line: MM.1S myeloma cells Concentration: 50 μM Incubation Time: 7 days Result: Decreased the level of phosphorylation of retinoblastoma protein (Rb).
References

[1]. Johansson C, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat Chem Biol. 2016 Jul;12(7):539-45.

[2]. Blair LP, et al. KDM5 lysine demethylases are involved in maintenance of 3'UTR length. Sci Adv. 2016 Nov 18;2(11):e1501662.

Density 1.1±0.1 g/cm3
Boiling Point 466.6±45.0 °C at 760 mmHg
Molecular Formula C17H28N4O3
Molecular Weight 336.429
Flash Point 236.0±28.7 °C
Exact Mass 336.216156
LogP 0.75
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.525